Filing Details

Accession Number:
0001181431-12-052005
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-25 17:45:12
Reporting Period:
2012-09-21
Filing Date:
2012-09-25
Accepted Time:
2012-09-25 16:45:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
820096 Perrigo Co PRGO Pharmaceutical Preparations (2834) 382799573
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242215 C Joseph Papa C/O Perrigo Company
515 Eastern Avenue
Allegan MI 49010
President And Ceo Yes Yes No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-09-21 15,000 $30.06 130,645 No 4 M Direct
Common Stock Disposition 2012-09-21 1,405 $115.72 129,240 No 4 S Direct
Common Stock Disposition 2012-09-21 13,595 $116.68 115,645 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option Right to Buy Disposition 2012-09-21 15,000 $0.00 23,794 $30.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
8,794 2010-08-25 2019-08-25 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1sales plan adopted by the reporting person on November 29, 2011. This 10b5-1 sales plan will expire on the close of business November 20, 2012.
  2. The price in column 4 is a weighted average. The prices actually received ranged from $115.24 to $116.23. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
  3. The price in column 4 is a weighted average. The prices actually received ranged from $116.27 to $1116.87. For all transactions reported in this Form 4 utilizing a weighted average price, the reporting person undertakes to provide upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.